These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35564749)

  • 1. Comparison of Analytical Values D-Dimer, Glucose, Ferritin and C-Reactive Protein of Symptomatic and Asymptomatic COVID-19 Patients.
    Pérez-García N; García-González J; Requena-Mullor M; Rodríguez-Maresca MÁ; Alarcón-Rodríguez R
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19.
    Qeadan F; Tingey B; Gu LY; Packard AH; Erdei E; Saeed AI
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of D-Dimer, C-Reactive Protein, and Ferritin with COVID-19 Severity in Pregnant Women: Important Findings of a Cross-Sectional Study in Northern Brazil.
    Paixão JTR; Santos CJSE; França APFM; Lima SS; Laurentino RV; Fonseca RRS; Vallinoto ACR; Oliveira-Filho AB; Machado LFA
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of D-Dimer, Ferritin, CRP and Lymphocyte Values in Determining Mortality in COVID-19 Disease in Turkey.
    Topcu H; Arik YE
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Serum Ferritin, D-Dimer, and C-Reactive Protein Parameters in COVID 19 Severity.
    Abdullateef Abdullah Z; Fouad Ali L
    Arch Razi Inst; 2023 Apr; 78(2):737-742. PubMed ID: 37396735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Laboratory Biomarkers Predict Survival In Severe Covid-19? A Cross-Sectional Study.
    Bahadur S; Rahim F; Amin S; Noor M; Gul H; Mahmood A; Usman M; Ullah R; Khan MA; Shahab K
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S919-S922. PubMed ID: 36550644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
    Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
    Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Covid-19 with blood type A in relation to blood sugar, urea, and blood test (D-dimer and ferritin) in patients from Al-Najaf.
    Hussein HJ; Ibrahim SA; Al-Shaibani SW; Abdulrudha NH
    J Med Life; 2022 Feb; 15(2):180-187. PubMed ID: 35419105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between laboratory parameters and CT severity in patients infected with Covid-19: A retrospective, observational study.
    Yilmaz A; Sabirli R; Seyit M; Ozen M; Oskay A; Cakmak V; Goren T; Turkcuer I
    Am J Emerg Med; 2021 Apr; 42():110-114. PubMed ID: 33503532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
    Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19.
    Huyut MT; Huyut Z
    Int Immunopharmacol; 2021 Nov; 100():108127. PubMed ID: 34536746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
    Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
    J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
    Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.